Landscapes / Targets

BET

12 drugs act on BET, in 42 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs12

DrugHow it worksCompanyStageNext dateDetails
Amyloid-beta protofibril antibody
Eisai +1 · Public BIIB
Approved 3 Dec 2026soonPhase 2 trial completes
Thyroid hormone receptor beta (THR-β) agonist
Approved Dec 2026Phase 3 trial completes
Amyloid-beta antibody (pyroglutamate amyloid beta in plaques)
Eli Lilly · Public LLY
Approved Nov 2027Phase 3 trial completes
—
Phase 2/3 22 Nov 2026soonPhase 1/2 trial completes
GARP/TGF-beta antibody
AbbVie · Public ABBV
Phase 2/3 Nov 2026soonPhase 2 trial completes
Amyloid-beta antibody with a transferrin receptor brain shuttle
Roche · Public ROG.SW
Phase 3 31 Jul 2027Phase 1/2 trial completes
Integrin beta-6-targeted antibody-drug conjugate
Pfizer · Public PFE
Phase 3 5 Sep 2028Phase 3 trial completes
—
Phase 1/2 Dec 2026Phase 1/2 trial completes
—
Phase 2 Dec 2026Phase 2 trial completes
THR-beta agonist unconfirmed
Phase 2 15 Sep 2027Phase 2 trial completes
—
AbbVie · Public ABBV
Phase 1 Jan 2027Phase 1 trial completes
—
Phase 1 30 Apr 2027Phase 1 trial completes

About this list

Checked
12 of 12 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow BET

Following is part of Solo: you see every change to BET the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in